DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,909,397 | +24.1% | 35,911 | +20.0% | 0.31% | +17.7% |
| Q2 2023 | $7,181,453 | -2.1% | 29,923 | +2.9% | 0.27% | -10.4% |
| Q1 2023 | $7,332,503 | +32.3% | 29,093 | +39.3% | 0.30% | -0.7% |
| Q4 2022 | $5,542,375 | -38.2% | 20,882 | -39.9% | 0.30% | -50.9% |
| Q3 2022 | $8,975,000 | +10.5% | 34,749 | +8.5% | 0.61% | +7.6% |
| Q2 2022 | $8,119,000 | +4.8% | 32,026 | +21.3% | 0.57% | +5.8% |
| Q1 2022 | $7,748,000 | -11.0% | 26,413 | -0.1% | 0.54% | -20.3% |
| Q4 2021 | $8,702,000 | +19.2% | 26,451 | +10.3% | 0.67% | -10.2% |
| Q3 2021 | $7,301,000 | +16.5% | 23,983 | +2.7% | 0.75% | -1.7% |
| Q2 2021 | $6,268,000 | +50.3% | 23,357 | +26.1% | 0.76% | +2.3% |
| Q1 2021 | $4,170,000 | +62.7% | 18,527 | +60.6% | 0.74% | +9.6% |
| Q4 2020 | $2,563,000 | +22.0% | 11,536 | +18.3% | 0.68% | -15.6% |
| Q3 2020 | $2,100,000 | +38.1% | 9,751 | +13.3% | 0.80% | -7.2% |
| Q2 2020 | $1,521,000 | +67.0% | 8,603 | +30.7% | 0.86% | +13.7% |
| Q1 2020 | $911,000 | -0.9% | 6,582 | +9.9% | 0.76% | +12.6% |
| Q4 2019 | $919,000 | – | 5,988 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |